TD completes acquisition of Cowen Inc. Learn more.

Charles Rhyee

Managing Director, Health Care - Health Care Technology

Liquid Biopsy Market Analysis

Charles Rhyee is a managing director and senior research analyst covering the health care technology and distribution space. Mr. Rhyee has been recognized in polls conducted by The Wall Street Journal and The Financial Times. In 2008 and 2009, Institutional Investor named Mr. Rhyee “Best Up & Coming Analyst” in the health care technology and distribution space. Prior to joining Cowen in February 2011, he was an executive director covering the health care technology and distribution sector for Oppenheimer & Co. Mr. Rhyee began his equity research career at Salomon Smith Barney in 1999. He holds a BA in economics from Columbia University. HCNon

Get In Touch

Start a conversation with Charles Rhyee


    Explore related thought leadership, reports, coverage and insights for Charles Rhyee.

    A doctor who is also a person of color is doing research at his desk, the image is of his hands typing on a white keyboard on a white desk. Representing disrupting the traditional clinical trial model and clinical trial diversity.

    Disrupting The Traditional Clinical Trial Model

    A variety of pharmaceuticals laid on top of a desk next to a calculator, representing our drug pricing outlook. Laid on top are a variety of pills of various colors.
    Ahead of the Curve®

    The Price Is (Not) Right: Discounts, 340B, Access, And IRA

    Health Care Innovation in Research and Development depicted by two lab scientist conducting research in a lab. Blue and white color scheme with two female Scientists.
    Ahead of the Curve®

    Modernizing R&D: A Primer On Decentralized Clinical Trials